Abstract
Early in the course of the 1959 nationwide oral poliovirus vaccination campaign in Costa Rica, a small, special and intensive study of oral vaccination was initiated there by the Yale Poliomyelitis Study Unit. The aims were to determine the effectiveness of vaccination, as measured by the rate of antibody conversions and antibody rises induced by the trivalent Lederle oral vaccine when given in two doses to a population of young children living in a tropical environment; to determine the prevalence of non-poliovirus enteroviruses in this juvenile population and their possible inhibitory effects upon the attenuated poliovirus vaccine strains; and to determine the duration of virus excretion by vaccinees and their young siblings, and the degree of intrafamilial spread of these viruses. It was also concerned with in vitro markers of the poliovirus strains recovered after one or two human passages; and, finally, dealt with the extent to which polioviruses could be recovered from flies trapped within the study area before and during the vaccination trial. Considerable knowledge was gained regarding the epidemiological problems which the use of oral vaccines entail.
The authors conclude, inter alia, that the immunizing capacity of the vaccine used was ”fairly good” and that its efficacy varied considerably for the three types of poliovirus. Type 3 poliovirus in the vaccine took well and also spread rapidly and well, infecting 85% of susceptible family contacts under 5 years old and reinfecting 25% of those who already had specific antibody. There was some evidence of interference with type 1 vaccine virus by other enteroviruses circulating at the time the first vaccine dose was given.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- HORSTMANN D. M., NIEDERMAN J. C., PAUL J. R. Attenuated type 1 poliovirus vaccine; its capacity to infect and to spread from vaccinees within an institutional population. J Am Med Assoc. 1959 May 2;170(1):1–8. doi: 10.1001/jama.1959.03010010003001. [DOI] [PubMed] [Google Scholar]
- HORSTMANN D. M., NIEDERMAN J. C., RIORDAN J. T., PAUL J. R. The trial use of Sabin's attenuated type 1 poliovirus vaccine in a village in southern Arizina. Am J Hyg. 1959 Sep;70:169–184. doi: 10.1093/oxfordjournals.aje.a120068. [DOI] [PubMed] [Google Scholar]
- HSIUNG G. D., MELNICK J. L. Effect of sodium bicarbonate concentration on plaque formation of virulent and attenuated polioviruses. J Immunol. 1958 Apr;80(4):282–293. [PubMed] [Google Scholar]
- LWOFF A., LWOFF M. Remarques sur les facteurs aspécifiques gouvernant l'évolution des infections virales; la notion d'état critique. C R Hebd Seances Acad Sci. 1959 Jan 5;248(1):154–156. [PubMed] [Google Scholar]
- RIORDAN J. T., PAUL J. R., YOSHIOKA I., HORSTMANN D. M. The detection of poliovirus and other enteric viruses in flies. Results of tests carried out during an oral poliovirus vaccine trial. Am J Hyg. 1961 Sep;74:123–136. doi: 10.1093/oxfordjournals.aje.a120206. [DOI] [PubMed] [Google Scholar]
- VOGT M., DULBECCO R., WENNER H. A. Mutants of poliomyelitis viruses with reduced efficiency of plating in acid medium and reduced neuropathogenicity. Virology. 1957 Aug;4(1):141–155. doi: 10.1016/0042-6822(57)90050-8. [DOI] [PubMed] [Google Scholar]
- WECKER E. A simple test for serodifferentiation of poliovirus strains within the same type. Virology. 1960 Mar;10:376–379. doi: 10.1016/0042-6822(60)90030-1. [DOI] [PubMed] [Google Scholar]